CD274 and neoplasm: Previous studies have demonstrated their pivotal roles in T-cell suppression, immune evasion, and tumor progression, and they have emerged as promising immunotherapy targets either either individually or in combination with PD-L1/PD-1 inhibitors [3, 19, 43, 96, 108].